Skip to main content
Equibles

MetLife Investment Management, LLC

Position in URGN — UroGen Pharma Ltd.

CIK 1529735 Whippany, NJ
Back to URGN Full portfolio

Position in URGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$915,032
+$495,631 QoQ
Shares Held
24,865
+6.6% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 190 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. URGN ranks #89 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in URGN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $915,032 24,865
2026-03-31 $419,401 23,326
2025-12-31 $525,661 22,445
2025-09-30 $454,181 22,766
2025-06-30 $311,894 22,766
2025-03-31 $251,791 22,766
2024-12-31 $242,457 22,766
2024-09-30 $254,495 20,039
2024-06-30 $336,254 20,039
2024-03-31 $219,390 14,626
2023-12-31 $219,390 14,626
2023-09-30 $145,746 10,403
2023-06-30 $107,671 10,403
2021-09-30 $123,694 7,354
2021-03-31 $168,579 8,654
2020-12-31 $180,019 9,990
2020-09-30 $192,707 9,990
2020-06-30 $260,938 9,990
2020-03-31 $178,221 9,990